Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (692)
Alkermes plc. (ALKS)
snyderman nancy lynn MD — Director
Shares
44,472
Price
$50.35
Total Value
$2.24M
Shares Held After
15,395
% of Holdings
74.3%
Alkermes plc. (ALKS)
Gaffin David Joseph — EVP, CLO, Alkermes, Inc.
Shares
2,034
Price
$48.58
Total Value
$98.81K
Shares Held After
225,456
% of Holdings
0.9%
Alkermes plc. (ALKS)
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Shares
9,000
Price
$48.58
Total Value
$437.22K
Shares Held After
69,389
% of Holdings
11.5%
PRECIGEN, INC. (PGEN)
Shah Rutul R — Chief Operating Officer
Shares
33,772
Price
$6.50
Total Value
$219.52K
Shares Held After
497,751
% of Holdings
6.4%
Contineum Therapeutics, Inc. (CTNM)
Stengone Carmine N. — Director
Shares
2,500
Price
$16.01
Total Value
$40.03K
Shares Held After
17,217
% of Holdings
12.7%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
16,589
Price
$23.05
Total Value
$382.36K
Shares Held After
9,110
% of Holdings
64.6%
Entrada Therapeutics, Inc. (TRDA)
5AM Ventures V, L.P. — 10% Owner
Shares
1,718
Price
$6.85
Total Value
$11.77K
Shares Held After
2,846,592
% of Holdings
0.1%
Entrada Therapeutics, Inc. (TRDA)
PARMAR KUSH — Director
Shares
1,718
Price
$6.85
Total Value
$11.77K
Shares Held After
2,846,592
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
238
Price
$522.88
Total Value
$124.44K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
282
Price
$521.52
Total Value
$147.07K
Shares Held After
324,681
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,517
Price
$520.80
Total Value
$790.06K
Shares Held After
324,963
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,627
Price
$520.12
Total Value
$1.37M
Shares Held After
326,480
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,266
Price
$519.06
Total Value
$657.12K
Shares Held After
329,107
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,215
Price
$518.00
Total Value
$629.37K
Shares Held After
330,373
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,133
Price
$516.94
Total Value
$585.70K
Shares Held After
331,588
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
857
Price
$515.84
Total Value
$442.07K
Shares Held After
332,721
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
365
Price
$514.82
Total Value
$187.91K
Shares Held After
333,578
% of Holdings
0.1%
PRECIGEN, INC. (PGEN)
Thomasian Harry Jr. — Chief Financial Officer
Shares
100,000
Price
$6.06
Total Value
$606.00K
Shares Held After
254,535
% of Holdings
28.2%
Adaptive Biotechnologies Corp (ADPT)
BOBULSKY SUSAN — Chief Commercial Officer, MRD
Shares
1,299
Price
$24.00
Total Value
$31.18K
Shares Held After
399,989
% of Holdings
0.3%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
1,044
Price
$323.69
Total Value
$337.93K
Shares Held After
0
% of Holdings
100.0%
Entrada Therapeutics, Inc. (TRDA)
5AM Ventures V, L.P. — 10% Owner
Shares
114,756
Price
$6.93
Total Value
$795.26K
Shares Held After
2,848,310
% of Holdings
3.9%
Entrada Therapeutics, Inc. (TRDA)
PARMAR KUSH — Director
Shares
114,756
Price
$6.93
Total Value
$795.26K
Shares Held After
2,848,310
% of Holdings
3.9%
BridgeBio Pharma, Inc. (BBIO)
Apuli Maricel — Chief Accounting Officer
Shares
2,000
Price
$80.06
Total Value
$160.12K
Shares Held After
127,401
% of Holdings
1.5%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
1,001
Price
$120.67
Total Value
$120.80K
Shares Held After
16,130
% of Holdings
5.8%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
8,103
Price
$119.95
Total Value
$971.94K
Shares Held After
17,131
% of Holdings
32.1%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
4,783
Price
$118.73
Total Value
$567.91K
Shares Held After
25,234
% of Holdings
15.9%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
8,267
Price
$117.93
Total Value
$974.95K
Shares Held After
30,017
% of Holdings
21.6%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
7,089
Price
$116.96
Total Value
$829.10K
Shares Held After
38,284
% of Holdings
15.6%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
14,222
Price
$115.87
Total Value
$1.65M
Shares Held After
45,373
% of Holdings
23.9%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
15,477
Price
$114.96
Total Value
$1.78M
Shares Held After
59,595
% of Holdings
20.6%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
4,700
Price
$113.18
Total Value
$531.94K
Shares Held After
75,072
% of Holdings
5.9%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
600
Price
$110.95
Total Value
$66.57K
Shares Held After
79,772
% of Holdings
0.7%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
2,202
Price
$110.03
Total Value
$242.28K
Shares Held After
80,372
% of Holdings
2.7%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
400
Price
$108.46
Total Value
$43.38K
Shares Held After
82,574
% of Holdings
0.5%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
8,956
Price
$106.96
Total Value
$957.89K
Shares Held After
82,974
% of Holdings
9.7%
CORCEPT THERAPEUTICS INC (CORT)
Mokari Atabak — Chief Financial Officer
Shares
4,200
Price
$105.54
Total Value
$443.25K
Shares Held After
91,930
% of Holdings
4.4%
ACADIA PHARMACEUTICALS INC (ACAD)
Thompson Elizabeth H.Z. — EVP, Head of Research&Dev
Shares
50
Price
$26.17
Total Value
$1.31K
Shares Held After
18,994
% of Holdings
0.3%
ACADIA PHARMACEUTICALS INC (ACAD)
Thompson Elizabeth H.Z. — EVP, Head of Research&Dev
Shares
16,508
Price
$26.13
Total Value
$431.35K
Shares Held After
19,044
% of Holdings
46.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$528.96
Total Value
$21.16K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$526.92
Total Value
$210.77K
Shares Held After
324,483
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,084
Price
$525.80
Total Value
$1.10M
Shares Held After
324,883
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
4,846
Price
$524.88
Total Value
$2.54M
Shares Held After
326,967
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,486
Price
$523.87
Total Value
$778.48K
Shares Held After
331,813
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
644
Price
$523.04
Total Value
$336.84K
Shares Held After
333,299
% of Holdings
0.2%
Vericel Corp (VCEL)
SIEGAL JONATHAN — Principal Accounting Officer
Shares
500
Price
$48.90
Total Value
$24.45K
Shares Held After
1,078
% of Holdings
31.7%
Vericel Corp (VCEL)
SIEGAL JONATHAN — Principal Accounting Officer
Shares
2,500
Price
$48.90
Total Value
$122.25K
Shares Held After
1,078
% of Holdings
69.9%
Vericel Corp (VCEL)
SIEGAL JONATHAN — Principal Accounting Officer
Shares
1,500
Price
$48.90
Total Value
$73.35K
Shares Held After
1,078
% of Holdings
58.2%
Nurix Therapeutics, Inc. (NRIX)
Hansen Gwenn — Chief Scientific Officer
Shares
3,847
Price
$23.38
Total Value
$89.95K
Shares Held After
121,338
% of Holdings
3.1%
Nurix Therapeutics, Inc. (NRIX)
van Houte Hans — Chief Financial Officer
Shares
2,845
Price
$23.38
Total Value
$66.52K
Shares Held After
44,927
% of Holdings
6.0%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
3,847
Price
$23.38
Total Value
$89.95K
Shares Held After
19,912
% of Holdings
16.2%
Showing 1–50 of 692 transactions (page 1 of 14)